#VASC23 Join Dr. Anoop Matthew discussing the role of transcatheter pulmonary valve implantation in patients with native RVOTs Anoop Mathew Jonathan Windram Dr. Akshay Bagai Janek Senaratne

Patients with prior CABG presenting with an ACS are often treated conservatively without PCI, which is associated with a higher risk of adverse events 🔗atherosclerosis-journal.com/article/S0021-… Pishoy Gouda Padma Kaul European Atherosclerosis Society @ELS_Cardiology #CvPrev

📣 The CCS have released the newest iteration of the #Guidelines on Fitness to Drive! 🚗 Follow along in this thread to see what's new and what's changed 🧵 Full text 👉 onlinecjc.ca/article/S0828-… #CJC 1/13

Using #QualityOfLife adjusted Days Alive and Out of Hospital in #ClinicalTrials may provide complementary information to traditional outcome metrics Justin Ezekowitz Pishoy Gouda Canadian VIGOUR Centre Michael Felker Heather Ross Christopher O'Connor #AHAJournals ahajournals.org/doi/10.1161/CI…

I love Sportsnet stats as much as the next guy… so thought I would offer a suggestion The Edmonton Oilers have won 100% of games were Connor Brown has scored a goal! 1. Mar 13 capitals W 7:2 2. Mar 21 buffalo W 8:3 3. Mar 26 Jets OTW 4:3 4. Apr 6 Calgary W 4:2 5. May 25 Dal ???

It’s going to be interesting to see how we advance this field in the next 5 years - I’d love to see us move to more personalized decision making that accounts for patient preferences!

Getting ready for an exciting #ACC25 Duke Clinical Research Institute UAlberta Med & Dent Canadian VIGOUR Centre

Here’s my guide to navigate the #ACC25 trials, coming this weekend and featured in many journals with a (very) high impact factor. 1. WARRIOR = Intensive medical therapy in women with ANOCA/INOCA 2. STRIDE = Semaglutide in type 2 diabetes and peripheral artery disease 3. API-CAT

Are you at #ACC25 ? Join us exploring the digital heart beats of cardiology at 9:30 as poster theatre 10!

The first day of #ACC25 is about to begin! See what sessions we'll be covering in the thread down below.

Important Late Breaker at #ACC25 but need to recognize 👉 low proportion of ACS patient, specifically STEMI 👉 how you define high bleeding risk matters, this was a higher bleeding risk cohort than prior trials 👉 may not be generalizable to European or North American population

👉25% on concomitant GLP-1RA and SGLT2i with no difference observed in efficacy or safety 👉 injectable is still preferred (⬆️ bioavailability), but will be amazing for our patients who are afraid of injectables

#ACC25 👨🏽‍🔬 #bentracimab may soon be an option to reverse #ticagrelor for patients with major bleeding or undergoing emergency surgery!

At #ACC25, DCRI fellow Pishoy Gouda shared the results of consent and recruitment communications studies from the RESILIENCE Trial, where augmented vs. standard informed consent processes had similar rates, and email recruitment was nearly twice as effective as patient portals.

New in Circulation #ahajournals, late-breaker at #ACC25 American College of Cardiology E-alerts to providers improved early recognition, referral, AVR rates, and survival for patients with severe & symptomatic AS in a clinical trial Mass General Brigham Sammy Elmariah MD MPH ahajrnls.org/3QVW0k4

🗞️ Implantable cardioverter-defibrillators in ischaemic versus non-ischaemic heart failure: Insights from the #VICTORIA trial European Society of Cardiology Journals Giuseppe Galati Amr Abdin Henry Han bit.ly/4jZCuz5